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Abstract  
Background: Diabetes Mellitus is one of the most occurring conditions of non- communicable 
diseases (NCDs) in the world. According to World Health Organization (WHO), diabetes 
mellitus causes 1.6 million deaths annually, and nearly 87% of non-communicable diseases 
deaths occurred in low and middle-income countries. In response to this serious issue, WHO 
introduced an innovative and action-oriented response called the Package of Essential 
Noncommunicable Disease (PEN) interventions to prevent and control NCDs. It can be applied 
especially for low-resource settings. Ministry of health (MoH) started the PEN Approach 
implementation in the West Bank in 2013 and completed implementation by 2015 in primary 
healthcare clinics (PHC).   
 
Aim: The study aim to evaluate the effectiveness of PEN Approach in controlling diabetes mellitus 
among diabetes mellitus type 2 (DMT2) patients following the Approach at the MoH clinics in the 
West Bank.  
 
Methods: A quantitative cross-sectional study design was used. Data collection was conducted by 
a tool developed to collect file-based data including HbA1c, and physical measurements including 
cholesterol, BMI, and waist circumference. Also surveillance STEPwise questionnaire was used 
for diabetes risk factors assessment. Proportional stratified sample method was used, and 500 
patients were selected purposively during the study period. 
v 
 
Findings:  the mean age of study participants was 60 years (standard deviation =10.4), more than 
half of them were females (56.1%). Two thirds of the participants lived in rural areas. One quarter 
of the participants were illiterate (27.7%), around half of participants (43%) finished their primary 
education.  
Almost half of the participants (48.2%) had a monthly income less than 1500 shekels. The majority 
of the participants (79%) were unemployed, 79% of the participants were married, and the mean 
of diabetes duration was 9.4 years (SD = 5.7).   
Analysis of the participants HbA1c levels showed significant decrease from the 1st visit to the 3rd 
visit after two years (P >0.001), there was an  increase in the percent of patients who reach optimal 
glycemic control (HbA1c >7%) form 32.8% in the 1st visit to 38.7% in the 3rd visit.  
Binary logistic model was done to predict improvement in glycemic control from participants’ 
characteristics. Glycemic control was significantly improved among females rather than males 
(OR=1.6, P<0.001), in younger patients (age group less than 50 years) rather than in elder patients 
(age group more than 60 years) (OR= 1.7, P<0.001). Patients with diabetes mellitus duration for 
less than 5 years were also had better glycemic control than patients with diabetes mellitus duration 
more than 20 years (OR= 1.9, P<0.001), and among patients with income level 1500-3000 shekels 
rather than in those with an income of <3000 shekels  (OR= 2.4, P>0.01). 
 
 
 
vi 
 
Conclusion: The results of this evaluation indicated that PEN Approach was effective in meeting 
objectives of controlling and managing DMT2.  The HbA1c levels among diabetic patients who 
were involved in the PEN Approach had significantly declined, and the percent of patients with 
optimal glycemic control increased after two years. 
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تقييم مرضى السكري المتابعين في عيادات الرعاية  )hcaorppA NEP( :لسارية برنامج الأمراض غير ا
 الأولية 
 
 برادعيةعبد الرزاق إعداد: إيمان مصطفى 
  نإشراف: د. معتصم حمدا
 
يعتبر مرض السكري أحد الأمراض غير السارية الأكثر انتشارًا في العالم, فحسب منظمة  ملخص الدراسة:
من هذه الوفيات تحدث  %78مليون وفاة سنويًا بسبب مرض السكري, حيث أن  6.1لصحة العالمية هنالك ا
في الدول المنخفضة والمتوسطة الدخل. واستجابة لهذا الوضع أدخلت منظمة الصحة العالمية برنامجًا مبتكرًا 
 ه بشكل خاص في الدول ذاتللأمراض غير السارية بهدف الوقاية منها والسيطرة عليها. إذ يمكن تطبيق
بدأت وزارة الصحة الفلسطينية بتطبيق هذا البرنامج في عيادات الرعاية  3102الموارد القليلة. في عام 
 .تم تطبيق البرنامج في جميع العيادات 5102الأولية التابعة للوزارة ومع نهاية عام 
لدم, ر السارية في تنظيم مستوى السكر في اتهدف الدراسة إلى تقييم مدى فعالية برنامج الأمراض غي الهدف:
 حةالرعاية الاولية في وزارة الص في مرضى السكري من النوع الثاني والذين يتبعون البرنامج في عيادات
  .الفلسطينية
اعتمدت الدراسة منهجية الوصف التحليلي, من خلال دراسة كمية مقطعية, حيث تم اختيار العينة  المنهجية:
 005بي من ثلاِث محافظات ومن ثم اختيار المرضى بشكل عمدي اذ بلغ حجم العينة بشكل طبقي نس
مريض, تم جمع البيانات من خلال أداة تم تطويرها لجمع قراءات فحص السكر التراكمي ومستويات 
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 esiwPETS الكوليسترول و مؤشر الكتلة ومحيط الخصر. تم اعتماد استبيان جاهز معد لبرنامج ال
  .ري وامل الخطرة المرتبطة بمرض السكمن أجل دراسة الع  ecnallievruS
), حيث كان نصفهم 4.01عامًا ( الانحراف المعياري =  06بلغ متوسط أعمار المشاركين بالدراسة  النتائج:
), ويعيش ثلثي المشاركين في المناطق الريفية, وكان ربع ٪1.65من الإناث اللواتي بلغن عددهن (
ين بينما أنهى نصفهم تعليمه الإبتدائي, وحوالي نصف المشاركين لديهم دخل شهري أقل المشاركين من الأمي
منهم  %97, وحوالي )97%(, ومعظم المشاركين بالدراسة عاطلين عن العمل )2.84%(شيكل 0051من 
أظهرت نتائج تحليل  .)7.5(الانحراف المعياري = 4.9متزوجين, وبلغ معدل فترة الإصابة بالسكري 
كما أن  ,)100.0<P( ات السكر التراكمي انخفاضًا ذا دلالة إحصائية ما بين الزيارة الأولى والثالثةمستوي
 %8.23بنسبة )%7 < c1AbH(هنالك ارتفاعًا في نسبة المرضى الذين حققوا أفضل تنظيم لمستوى السكر
 .في الزيارة الثالثة %7.83في الزيارة الأولى إلى 
 ي الثنائي للتنبؤ بخصائص المشاركين التي تساهم في تحقيق تحسن في تنظيمتم تطبيق الانحدار اللوجست 
السكر في الدم, حيث أظهرت النتائج أن الإناث حققن تحسنًا أفضل في مستويات السكر بالدم مقارنة 
عامًا حققوا تحسنًا أفضل في  05, كذلك المرضى الذين تقل أعمارهم عن   )100.0<P ,6.1=RO(بالذكور
  ,7.1=RO( )100.0<P    عاما ً06السكر بالدم مقارنة بالمرضى الأكبر سنًا ممن يزيدون عن  مستويات
سنوات مقارنة بمن تزيد فترة  5أظهر هذا التحليل أيضًا تحسنًا لدى المرضى الذين تقل فترة إصابتهم عن .
-0051ي , كذلك حقق المرضى ممن دخلهم الشهر  )100.0<P ,9.1=RO( عاما02الإصابة لديهم عن 
   )10.0<P ,4.2ل شيك 0003ارنة بمن دخلهم أكثر من تحسنًا أفضل في مستوى السكر مق 0003
 .=RO(
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قد نجح في تحقيق جزٍء من أهدافه  hcaorppA NEP تشير نتائج هذا التقييم إلى أن برنامجالخلاصة:
 ًا في مستوى السكربتنظيم وإدارة مرض السكري من النوع الثاني, حيث أن المرضى قد أظهروا انخفاض
 .وارتفعت نسبة من حققوا أفضل تنظيم لمستوى السكر المطلوب
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Chapter One 
Introduction 
 
1.1 Background: 
 
Diabetes mellitus type 2(DMT2) is one of the most occurring conditions of non-communicable 
diseases in the world. It spreads in developed countries as same as in developing countries, and 
causes rapidly growing public health problems (Chan, 2009). Harmful complications of 
DMT2such as, cardiovascular diseases, renal failure, retinopathy and neuropathies make it the 
fourth leading cause of death in the world (Roglic, 2005). According to WHO, DMT2 is the cause 
of 1.6 million deaths annually. In addition, 2.2 million deaths occurs yearly as a result of high 
blood glucose levels. Nearly 80% of these deaths occurred in low and middle-income countries 
(WHO, 2013). 
DMT2 is a chronic progressive disease characterized by elevated blood glucose levels 
(hyperglycemia) (Michael, 2008). WHO has defined DMT2 as “group of metabolic disorders 
characterized by hyperglycemia, occurs either when the pancreas does not produce enough insulin 
or when the body cannot effectively use the insulin it produces”( Fowler,2008).  
There are many types of diabetes and the classification of these types depends on the presumed 
etiology that leading to diabetes. Most common known are type 1 and type 2, other types less 
common occurred like gestational diabetes (IDA, 2012).  
2 
 
DMT2 accounts for the vast majority of people with diabetes around the world. It results from the 
insulin resistance in the liver and skeletal muscles, it also characterized by relative insulin 
deficiency due to Beta cells failure. Patients can manage type 2 diabetes initially by modifying 
some behaviors related to exercise and diet, but many of them need to take drugs or insulin to 
control the condition (Stumvoll M, 2005). 
Risk factors for DMT2 is divided into two categories, modifiable and non-modifiable risk factors. 
Modifiable risk factors include contributing factors related to person’s behaviors like physical 
inactivity, diet, smoking, and obesity (Badran, 2012). Different measures are recommended to 
assess diabetes control, one of these measures is testing glycosylated hemoglobin (HbA1c) (ADA, 
2012). 
 
Non-communicable diseases (NCD) burden is increasing more rapidly in lower income countries 
and populations (WHO, 2017). Consequently, the World Health Organization (WHO) had 
introduced an innovative and action-oriented response called “the Package of Essential 
Noncommunicable Disease Interventions (PEN).The PEN approach uses the primary health care 
(PHC) units to prevent and control NCDs, and can be applied especially for low-resource settings. 
It makes sure supplying a set of needed interventions of acceptable quality and cost effectiveness. 
As diabetes mellitus is one of NCDs widely spread globally, PEN Approach can also be considered 
as appropriate protocol for diabetes management especially in low-income societies (WHO, 2010).  
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Implementation of PEN Approach is an essential part of the objective 4 of the Global Action Plan 
(2013-2020) which stated  “strengthen and orient health systems to address the prevention and 
control of noncommunicable diseases and the underlying social determinants through people 
centered primary health care and universal health coverage” (WHO,2013). This implementation 
of the approach will allow early detection and management of non-communicable diseases.  
 
Health impact objectives of PEN protocol have been beneficial on health through reduction of 
tobacco consumption in NCD patients; reduction of the average delay in the diagnosis of NCD by 
the health services (i.e. reduction of the risk of heart attacks, strokes, amputations and kidney 
failure); reduction of case fatality of major NCDs, prevention of acute events and complications 
and prolongation of the duration of stable clinical periods for CVDs, diabetes, asthma patients 
(WHO, 2010).  
 
In Palestine, as a lower-middle income country, the Ministry of Health (MoH) took responsibility 
to implement PEN approach in order to manage and control non-communicable diseases. Palestine 
was the second country started applying PEN approach after Sri-Lanka. First training on protocol 
was conducted in September 2012 in Salfit district. Actual implementing of the program started in 
2013 in Salfit district then, in most PHCs of West Bank cities by the end of 2015.   
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1.2 Study problem: 
 
Health services in Palestine are provided by several organizations: the MoH, the United Nations 
Relief and Works Agency (UNRWA), Non-governmental organizations (NGOS) and the private 
sector.  Health system in Palestine is challenged by a variety of obstacles due to the current political 
and economic situation, some of the specialized tertiary health care services are still provided by 
overseas providers.  
Chronic diseases are considered a major burden on health systems, in general, where patients are 
in need for care for the whole of their lives. In addition to the high probability of complications if 
chronic cases are not being controlled and managed properly. This would also has a high financial 
burden on people and health care system (ADA, 2012).  
To manage and control chronic diseases in Palestine the MoH adopted the Package of Essential 
non-communicable (PEN) approach. After introducing the PEN program in all health departments 
in 2015, the health status of diabetic patients who were being monitored by the PEN approach had 
not been assessed. It is necessary to assess the impact of PEN Approach on health status of these 
patients to detect the efficiency of the PEN Approach in managing and controlling diabetes.   
 
There is no studies in Palestine aimed to evaluate health outcomes of PEN approach, which is the 
only protocol for managing diabetes in the governmental sector. This study aimed to assess health 
outcomes and changes in risk factors of patients with diabetes who attending the PEN approach. 
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1.3 Study justification: 
 
DMT2 and its complications are among the most important health issues facing the health sector 
in general, the prevalence rate in 2000 was 10.5% and in the last 10 years the numbers of diabetic 
patients visiting the clinic have doubled, where a report issued by the MoH in 2015 has indicated 
that the prevalence of diabetes in Palestine is 12% (MoH, 2015). 
The PEN Approach program aims to manage and control the health status of diabetic patients 
through committing to a group of protocols that monitor the patient and the medication they use 
and the required examinations that ordered at specific schedule. This program relies majorly on 
directing the patient through counseling and providing the accurate information about risk factors 
which usually links to the life style (WHO, 2010).  
The health status of Palestinian patients need to be evaluated, especially, it has been two years 
since the full implementation of the program in all governorates. The study importance stems from 
the seriousness of the diabetes, one of the major causes of death in Palestine (MoH, 2015).  
This study would provide preliminary information to decision makers and officials about the 
efficiency of the PEN program in managing diabetic patients, and the need to take the results into 
account when making decisions related to the development and sustainability of this program. 
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1.4 Study objectives: 
 
The study aim was to evaluate the effectiveness of PEN Approach in controlling diabetes among 
DMT2 patients following the adopting Approach in the MoH clinics in the West Bank.  
 
1.5 Specific objectives: 
- To assess diabetic patients’ anthropometric measurements (height, weight, BMI and waist 
circumferences, blood pressure) and laboratory tests (HbA1c and cholesterol) among 
patients following introducing the PEN approach. Readings will be taken at the beginning, 
after one year and after two years of following the approach. 
- To estimate burden of complications of diabetes such as eye, foot, heart and kidney 
complications among patients following the PEN approach.  
- To examine possible changes in some diabetes risk factors; BMI and cholesterol, also 
examine other factors in current situation; smoking, physical activity, and diet among 
patients following the PEN Approach.  
- To assess the association between characteristics of patients following the program also 
the changes in the physical measurement and glycemic control represented by HbA1c.   
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1.6 Study limitations: 
- Study mainly depends on patients’ files, and some files may be not completed or were not 
properly documented especially for physical measurements of patients.  
- The study is a cross-sectional study, cause- effect relationship can’t be determined between 
dependent and independent variables.  
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Chapter Two 
Literature Review 
 
 
2.1 Epidemiology of Type 2 diabetes mellitus: 
 
2.1.1Diabetes worldwide 
 
DMT2is a common worldwide health issue. WHO estimates that globally, 422 million adults were 
living with diabetes in 2014. The number of diabetic patients has continuously increased over the 
past few decades, due to population growth and increase in the lifespan of the population. 
Universally, between 1980 and 2014, number diabetic patients has substantially increased from 
108 million to four times higher, and the prevalence has grown from 4.7% to 8.5%. According to 
WHO, DMT2 is reported as a sixth leading cause of death in the world (WHO, 2017). 
An estimation of the prevalence of diabetes for 2010 and 2030 reported that North America has 
the highest prevalence of type 2 diabetes mellitus for 2010 at a prevalence rate of 10.2%, followed 
by the Eastern Mediterranean and Middle East (EMME) and South Asia at a prevalence of 9.3% 
and 7.6% respectively (Shaw, 2010).In 2011, many countries in the Arab world had a high 
prevalence of DMT2, and some Arab countries were classified in the top 10 countries in the world 
regarding to the International Diabetes Federation (IDF). 
 
Furthermore, the 2016 Annual report of the United Nations Relief and Works Agency (UNRWA) 
had reported that the prevalence of Type 2 diabetes mellitus among the refugees population aged 
9 
 
40 years and above was 12.1% compared to 10.5% in 2010. The report also revealed that the West 
Bank field (15.9%) had the highest rates of DM, followed by the Gaza Strip (12.9%), Jordan 
(11.5%), Syria (11.1%) and Lebanon (8.4%) (UNRWA, 2016).  
 
2.1.2 Diabetes in Palestine 
 
Diabetes mellitus is a major health challenge to health system in Palestine. In 2000, the prevalence 
of DMT2 was 9% among adults (MoH, 2006). Data from the STEPwise survey in West Bank 
(2010-2011) showed that the prevalence of DM is 12.7% in adults, 14.2% and 11.1% among males 
and females respectively. Same STEPwise survey reported that 9 out of every 10 Palestinians have 
at least one risk factor for a non-communicable disease (WHO, 2012). About 58% of men and 
women aged 15–64 are overweight and of these, 27% are obese, 75.3% do not exercise and 20% 
are currently smoking (WHO, 2012).  
According to WHO, The number of new cases in Palestine reported annually, has ranged from 150 
to 220 per 100,000 population, but reported cases are considered to represent half of actual cases 
(WHO, 2016).  
A study was conducted in 2013 by Abu-Rmeileh provided estimates for future diabetes prevalence 
in the West Bank. It predicted that prevalence of DMT2 will be 20.8% for 2020 and 23.4% for 
2030. A 2.8% reduction in diabetes prevalence could be achieved if obesity trends start to decline 
by 5% in a 5-year period (Abu-Rmeileh 2013).  
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2.2 Type 2 diabetes mellitus Management: 
 
2.2.1 Glycemic control: 
 
Glycosylated Hemoglobin (HbA1c) was used to examine diabetes control since it reflects glycemic 
situation of the patient during previous three months. According to ADA, controlled glycemia is 
achieved by value of HbA1c less than 7%. Currently, HbA1c test is considered as a standard 
parameter used to manage DMT2 properly, and an indicator to predict diabetes complications 
(Martin, 2006;Woerle, 2007).  
Various studies have pointed out the significance of strict glycemic control to have HbA1c less 
than 7% for diabetic patients in order to reduce the risk of developing micro-vascular and macro-
vascular complications. These studies showed that diabetes related complications can be avoided 
by controlling and managing glycemic levels (Ozcelik, 2010; Benhalima, 2011; ADA, 2012).  
The United Kingdom prospective diabetes study (UKPDS) demonstrated that the reduction in the 
HbA1c level by 1% will reduce the risk of micro-vascular complications by 37% (Stratton, 2000). 
This reduction will be life-long if patient control HbA1c to < 7% in a short time after diagnosis 
(ADA, 2011). 
In Palestine, a survey performed by Birzeit University in 2012, to study management, 
complications and quality of life among patients with DMT2. The results indicated a high 
prevalence of complications related to DMT2 in Ramallah governorate clinics. It also showed a 
significantly higher ratio of un-controlled patients (HbA1c ≥7%) with retinopathy, nephropathy 
and neuropathy in contrast to others with HbA1c less than 7% (Mikki, 2012).  
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2.2.2 Behavioral modifiable risk factors: 
 
 Body Mass Index (BMI) 
Increased Body mass index (BMI) is a strong risk factor for diabetes and insulin resistance. In an 
obese individual, the amount of substances that are involved in the development of insulin 
resistance are increased. Insulin resistance with impairment of β-cell function leads to the 
development of diabetes (Valdes, 2007; Lyssenko, 2008; Al-Goblan, 2014). Previous studies 
demonstrated that weight loss will lead to progressive decline in HbA1c levels (Muchmore, 1994).  
The Nurses' Health Study, began in 1976 and proceeded for 16 years of follow-up, had registered 
3300 new cases of DMT2 from 121,700 participants. The most important predictor of diabetes was 
overweight or obesity. The relative risk of diabetes was 38.8% for women with a body-mass index 
of 35.0 or higher and 20.1% for women with a body-mass index of 30.0 to 34.9 in comparison to 
women with a body-mass index less than 23.0 (Hu FB,2001).  
A study conducted in West Bank, showed a relationship between obesity and central obesity and 
some morbidities including DMT2. Significantly higher prevalence of central obesity among men 
rather than women (Abdul-Rahim, 2001).  
 
 Smoking  
Several prospective studies reported that smoking is a risk factor for developing DMT2 (Gress, 
2000;Kumari, 2004). This could be due to the direct effect of nicotine or other components of 
cigarette on beta cells of the pancreas as suggested by the association of cigarette smoking with 
chronic pancreatitis and pancreatic cancer (Talamini, 1999).  
A prospective study was conducted in UK (2001) reported that cigarette smoking was associated 
with a significant increase in risk of diabetes. Even after adjustment for age, BMI, and other 
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potential confounders. The benefit of giving up smoking was only apparent after 5 years of 
smoking cessation (Goya Wannamethee, 2001). A meta-analysis including 25 prospective studies 
showed that current smoking was associated with a 44% increased risk of diabetes (Willi, 2007).  
In Saudi Arabia, a survey showed that diabetes appears to be significantly associated with daily 
smoked tobacco products (Saeed, 2012).  
 
 
 Physical inactivity  
Physical activity is a major parameter in DMT2 management. Recommendations advised diabetic 
patients to do exercises 150 min/week of moderate –intensity activity. Exercises play an important 
role in improving blood glucose levels, decrease risk to cardiovascular diseases and help in weight 
loss (Weinstein, 2004; Fretts,2009). 
Longitudinal studies have found physical inactivity to be a strong risk factor for type 2 diabetes 
(Fretts,2009;Gimeno, 2009). Evidence from clinical trials, which included physical activity as an 
integral part of life style interventions, suggested that onset of type 2 diabetes can be prevented or 
delayed because of successful lifestyle interventions that included physical activity as a part of this 
interventions (Pan, 1997; Tuomilehto, 2001; Ramachandran, 2006).  
Although regular physical activity (PA) may prevent or delay diabetes and its complications, most 
people with type 2 diabetes are not active (Colberg, 1996; Balducci, 2006;Morrato, 2007).  
In meta-analysis study conducted to evaluate the effects of exercise interventions in patients with 
type2 diabetes reported that most of the studies concluded that HbA1c mean levels have declined 
in intervention group compared to control group (Boulé, 2001).  
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 Dietary pattern 
Controlled dietary pattern is an important element in prevention and management of DMT2 
Recommendations to diabetic patients is to follow a healthy diet which includes dietary habits and 
managing meals times (Yannakoulia, 2006) 
 Positive association hasbeen reported between the risk of DMT2 and different patterns of food 
intake (Schulze, 2004; Liese, 2009). A review on the role of fats and carbohydrates on type 2 
diabetes concluded that a higher intake of polyunsaturated fat and possibly long-chain fatty acids 
could be beneficial. Whereas, a higher intake of saturated fat and trans-fat could adversely affect 
glucose metabolism and insulin resistance (Hu, 2001). In addition, a low-glycemic index diet with 
a higher amount of fiber and minimally processed whole grain products reduces glycemic and 
insulinaemic responses and lowers the risk of DMT2. This leads to a conclusion that, to prevent 
and manage diabetes, a greater attention should be drawn on the quality of fat and carbohydrate in 
the diet than quantity alone (Hu, 2001). Another studies showed that higher consumption of fruits 
and vegetable was associated with reduced risk of DMT2 (Montonen, 2005).  
A longitudinal study conducted among men demonstrated that higher consumption of processed 
meat was related with a higher risk for DMT2 (relative risk=1.46, for more than five times a week 
vs. less than once per month, p<0.0001) (Van Dam, 2002). Another study suggested that limiting 
the amount of red meat as compared to chicken had a significant effect on HbA1c,fasting blood 
glucose and cholesterol levels (Gross, 2002) 
Progressive improvements in HbA1c levels decreased by 1-2% in DMT2 patients when they 
followed up by dietitian after three to six months (ADA, 2008).    
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Policies and programmes focusing on reducing the burden of these common risk factors are very 
critical to decrease rate of diabetes. Early management of non-communicable diseases risk factors 
help avoiding its complications. The quality of life will improve and the expenditure on the 
secondary (curative) care will be decreased (WHO, 2011) 
 
2.3 Evaluating Studies: 
 
Evaluation studies have been conducted in many countries to evaluate health programmes. In 
NCDs field, studies were conducted to evaluate health outcome of approaches used to control and 
manage non-communicable disease. 
Some studies showed a better progression of type 2 diabetes patients after a period of management 
and follow up. In Norway, a study was carried out to assess changes in the quality of care for 
patients with type 2 diabetes.  Two cross-sectional surveys were used to examine and identify 
patients with type 2 diabetes who attended selected clinics between 1995 and 2005. Significant 
improvements were observed among patients by their smoking habits, height, weight, and referral 
to eye examination. Mean HbA1c decreased from 7.74 to 7.15%, systolic blood pressure from 150 
to 140 mmHg, and cholesterol from 6.28 to 5.0 mmol /l (P < 0.001)(Cooper, 2009).  
 
In Bhutan (2014), a descriptive study was conducted to evaluate the performance of the PEN 
project in detecting and managing NCDs and their risk factors. Data were collected from the 
clinical forms, supervisor’s report and monthly reports of the PEN project. Results showed that 
among 444 patients who had three follow-up visits, high 10-year-CVD risk (>20%) had declined 
from 13% to 7.3%. Among 400 patients with hypertension, adherence to medications was 
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increased and high blood pressure declined from 42.3% to 21.5%. Among 115 patients with 
diabetes, adherence to medications was increased and high blood sugar declined. The study 
concluded that implementation of the PEN intervention in the primary health care settings of 
Bhutan led to improvement in blood pressure and diabetes control and reduction in CVD risk 
(Wangchuk, 2014).  
 
A retrospective cohort study was carried out in Jordan (2012) aimed to report outcomes and 
complications of type 2 diabetes mellitus among Palestinian refugees in Jordan. The results 
indicated that 71–78% of patients had blood glucose ≤180 mg/dl; 63–74% had cholesterol <200 
mg/dl; and about 90% had blood pressure <140/90 mmHg. Obesity remained constant at 50%. The 
proportion of patients with late-stage complications increased from 1% at baseline to 7% at 1 year, 
14% at 2 years and 15% at 3 years (Khader, 2012).  
 
In Korea, a study has been conducted in 2017 to check outcomes of piloting WHO PEN protocols 
and assess the feasibility of integrating PEN Approach into the local primary healthcare system. 
The study concluded that the primary healthcare clinic doctors were able to detect and control risks 
for diabetes and cardiovascular disease after training to use the protocols of PEN Approach. 
Among 18,340 individuals aged over 35 years, implementation of WHO PEN interventions led to 
a significant reduction in the percent of people with a 10-year risk of cardiovascular disease ≥20% 
(from 9.5% to  3.0%) over a 1-year period. Patients with fasting blood glucose level of >7 % 
declined from 27.7% to 10.0% and the blood cholesterol level of >6.6 mmol/L declined from 
(10.7%) to (3.2%) among individuals included in study (Hyon, 2017). 
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Chapter Three 
Conceptual framework 
 
3.1 Introduction: 
 
This chapter discusses the conceptual framework of the study, it also present dependent and 
independent variables.  
 
3.2 Independent variables: 
 
3.2.1 Socio-demographic variables: 
 
- Age: represented in files by date of birth, researcher use it to calculate respondent’s age.  
- Sex: categorized into “male” and “female” to check sex association withHbA1c.  
- Marital status this variable was categorized into four groups, constructed as follows: 
‘single’, ‘married’, ‘divorced’ and ‘widowed’.  
- Level of income: Categorized into three categories according to PEN files classification 
“less than 1500 Sheikls”, “1500-3000”, “more than 3000”.  
- Level of education: The educational level of patients was constructed into four categories 
that represent the educational level in Palestine:  "illiterate”, “primary school”, secondary 
school”, and “university”.  
- Place of residency: categorized into urban/rural/camp was based on the 2007 Palestinian 
Central Bureau of Statistics (PCBS) classification (PCBS, 2007).  
- Employment: categorized into “employed” and “unemployed” regardless work type.  
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3.2.2Variables of Disease-Related Characteristics: 
 
- Disease duration: registered in files as date of diagnosis, calculated and categorized into 
"less than5”, “6-10”, “ 11-15”, “16-20”, “more than 20” years according to previous study 
conducted in Palestine to evaluate applied programme for diabetes management in Augusta 
Victoria hospital(Khatib, 2013). 
- Medications: the treatment type that patient has taken categorized into “oral tables”, 
“insulin”, and “mixed”.  
- Diabetes complications: diabetes complications including; neuropathy, nephropathy, 
diabetic foot, dyslipidemia, hypertension, eye problems.  
 
3.2.3 Laboratory tests and physical measurements: 
 
- Cholesterol: total cholesterol is analyzed and its results registered in patients files, 
reference value for total cholesterol should be less than 200 mg/dl (Roth, 2010). 
Cholesterol test should be done for each patient once a year at least, and if there is a need 
could be more according to PEN protocols.  
- Blood pressure: blood pressure measurements of systolic and diastolic readings. Normal 
values for blood pressure is lower than 138/80 mmHg (WHO, 2012).  Blood pressure 
readings should be taken every visit according to PEN protocols.  
 
- Waist circumference: provides an estimate of body girth at the level of the abdomen 
(Klein, 2007). Waist circumference cutoff values for substantially increased in diabetes 
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mellitus risk are102cm for men and 88cm for women according to WHO (WHO, 2012). 
Waist circumference measurement is taken every visit according to PEN protocols.  
 
3.2.4 Diabetes risk factors: 
 
- Body Mass Index (BMI): an index used to examine obesity condition of individuals, it is 
calculated through dividing weight in kilograms by square of height in centimeters.  
Persons who have BMI ≥25 classified as overweight, BMI ≥ 30 classified as obese (WHO, 
2004).Files reported patients weight every visit and height in the first one. 
- Physical activity: basic part of STEPwise questionnaire related to physical activity is used 
to describe physical activity of participants. 
- Dietary pattern: basic part of STEPwise questionnaire related to diet is used to describe 
dietary pattern of participants, questions related to daily intake of fruits and vegetables, and 
consumption of processed food. 
- Smoking: participants were asked if they are current smokers or not, also if they smoked 
previously and had stopped stop, how many cigarettes they smoke daily.  Check annex 1 
and 2.  
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3.3 Dependent variable: Glycosylated hemoglobin (HbA1c): 
 
HbA1c is a blood test that reflects the average blood glucose during preceding two to three months. 
It shows the amount of glucose that stick to hemoglobin which is proportional to glucose levels in 
blood (ADA, 2012). According to ADA, individuals with HbA1c levels less than 7% is classified 
as “good controlled”, and others who’s HbA1c level equal or more than 7% are classified as 
“poorly controlled” (ADA, 2007).  
The general concept to measure glycated hemoglobin is to separate the glycated from 
nonglycated hemoglobin and quantify its’ amount. This separation based on charge differences; 
ion-exchange chromatography, high performance liquid chromatography (HPLC), 
electrophoresis and isoelectric focusing, or chemical analysis; photometry and 
spectrophotometry, or structural differences; affinity chromatography and immunoassay (Sacks 
DB, 1994).   
The reference method to measure HbA1c is high performance liquid chromatography (HPLC), 
many studies concluded that some methods of measuring HbA1c may give results away from 
HPLC results (Sack, 2012).  
  
 To overcome this issue, researcher contacting the quality control center in MoH check which 
method is used, and he assures that all labs used the same method to measure HbA1c which is 
boronat affinity chromatography. And there is a periodically check for quality control of HbAIc 
test for all MoH labs.  
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3.4 Conceptual framework: 
 
The conceptual framework used in the study is provided in Figure (3.1).  
 
 
Figure (3.1): conceptual framework of study. 
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Chapter Four 
Methodology 
 
4.1. Introduction 
 
The aim of this study was to evaluate glycemic control of DMT2 patients following PEN Approach 
in MoH health clinics. In this chapter, the research’s methodology will be described including 
study design, study setting, sampling method and sample size.  
 
4.2. Description of the PEN Approach used in Diabetes management 
 
All patients attending the primary health care clinics who have type 2 diabetes mellitus are 
registered by the clinic nurse. In addition, all patients who are aged over 40 years are screened by 
asking about their lifestyles and measuring their blood pressure, height, weight and waist 
circumference. Patients who overweight or obese or have a high waist circumference (body mass 
index (BMI) ≥23 kg/m2 or waist circumference >80 cm in women and >90 cm in men) undergo 
blood glucose testing.   
A PEN clinical form is filled for patients who had DMT2, clinical laboratory counselling and 
medication data are recorded in the clinical form. This form has three sections:  
- Section I records identification and sociodemographic data including sex, date of birth, 
income level, education level and marital status. In addition, clinical diagnosis including 
name of NCD disease and date of diagnosis are registered in this section.  
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- Section II records results of laboratory tests such as, fasting blood glucose (FBG), HbA1c 
and cholesterol. Blood pressure, weight and height measurements are, also, included in this 
section.   
- Section III records medications and counselling data. A definitive date of follow up visits 
is entered in the clinical form. 
 
During the follow-up visit, patient’s clinical record is retrieved; clinical and laboratory 
investigations are performed according to PEN protocols and counselling provided and the data 
are recorded in the clinical form. Patients are asked whether they have taken all medications 
regularly since their last visit, and their prescriptions are refilled. Health workers entered patients’ 
blood pressure, weight, and blood glucose test results in patients’ files. Patients are expected to 
visit once every three months or more if needed.  
 
4.3. Study Design 
 
A cross-sectional quantitative study design was employed to achieve study objectives. This type 
of studies was used in the study case, since the researcher used patient’s files mainly to collect data 
and ask patients some questions to get complete needed data.  
 
4.4. Sampling methodology 
 
Two stage-stratified sampling was employed. West Bank area was divided into three strata: North, 
Middle and South areas. From each strata, a random selection of one governorate was adopted 
23 
 
(North, Jenin; Middle, Ramallah, and South, North-Hebron). In addition to the central 
governmental clinic.  Also, two village clinics were selected randomly from each directorate.  
Within the clinics, a purposive sampling method was used in the selection of patients. . In this 
technique, the researcher included all patients who came to clinics during the study period and met 
the study inclusion criteria.  
Sample size was calculated by using Raosoft® sample size calculator, the minimum recommended 
sample size was 381participants. The study sample included 500 participants to overcome any 
effects related to study design. Check tables (4.1) and (4.2).  
 
Table 4.1: Sampling frame of the study. 
Palestinian Strata  Governorate Number of patients 
(Sample) 
North Jenin 11,596 
Middle Ramallah  5,419 
South  North- Hebron 5,068 
Total in West Bank 35,236 
 
Inclusion criteria: 
- Patients diagnosed with DMT2 who are registered on PEN Approach and had spent at least 
two years in the programme were included.  
Exclusion criteria: 
- Patients diagnosed with any type of diabetes other than DMT2, and patients who had spent 
less than two years in the program were excluded.  
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Table (4.2): Sample size from each Governorate:  
Area Frequency Percentage 
        North (Jenin) 209 43.5% 
        Middle (Ramallah) 130 27% 
       South ( North Hebron) 142 29.5% 
Total 481 100% 
 
4.5. Settings of the study 
 
The study was conducted in the West Bank, specifically in primary health care units (PHC) of 
Ministry of Health. Because the PEN Approach is applied in PHCs as a first line for managing and 
controlling DMT2 in governmental sector.  
 
4.6. Instrument of the study: 
 
The study instrument consisted of two parts, one developed by researcher to get the needed data 
from PEN files including the socio- demographic information of patients, values of diabetes 
controls includes blood glucose, HbA1c, cholesterol, body mass index (BMI) and blood pressure. 
Readings of those controls will be taken at baseline, after one year, and after two years. Also, the 
first part included data related to any complications associated to diabetes such as eye, foot, heart 
and kidney complications. And follow up, education, and medications information.  
The other part included data related to diabetes risk factors and not available in PEN files, were 
collected by STEPwise questionnaire (STEPS Instrument.Version 3.2) for non-communicable 
diseases risk factors surveillance (Arabic version).  
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4.7. Data collection: 
A permission to collect data from PEN files was received from the MoH as a first step in the data 
collection phase. Study instrument consisted of two parts, data collection from files by researcher, 
and structured questions for patients asked by researcher herself. Data collection process was 
conducted between October to December 2017. The consent form was attached to each 
questionnaire. Participants were informed about the aim of study, the confidentiality of data 
collected and the voluntarily participation.  
 
4.8 Data Analysis 
 
Data was analyzed by using Statistical Package for Social Sciences (SPSS® version 23.0). At the 
first phase, statistical descriptive analysis was conducted for demographic data, anthropometric 
measurements and diabetes controls. At the second phase, univariate analysis was applied 
including; One-Way ANOVA of repeated measures was used to check if there is a significant 
change in HbA1c, cholesterol, and BMI means. Chi-Square test was used to examine the 
relationship between independent variables and dependent variable. At the third phase logistic 
regression model was conducted for variables that showed significant association with HbA1c 
change.  
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4.9 Validation of the instrument  
The instrument of the study was obtained from STEPwise Approach questionnaire which is used 
by WHO to measure risk factors of non-communicable diseases that included type 2 diabetes 
mellitus. Other part related to socio-demographic anthropometric measurements, and diabetes 
controls were selected regarding to previous studies (Khader, 2014). Instrument as a whole was 
reviewed by experts in the research field and others directing PEN Approach applying from WHO 
and MoH.  
 
4.10 Ethical consideration:  
- The research committee of School of Public Health at Al-Quds University provided ethical 
approval to conduct this study.   
- Ministry of Health provided permission to perform the study and collect data in its clinics. 
- All patients provided verbal and written consent to participate in the study before data 
collection.  
 
 
 
 
 
 
27 
 
Chapter Five 
Results 
 
5.1 Introduction: 
This chapter includes the study findings. Socio-demographic characteristics of participants, results 
related to diabetes characteristics and risk factors. In addition, results of statistical analysis for 
associations between dependent and independent variables.  
5.2 Descriptive analysis: 
5.2.1 Socio-demographic characteristics of the participants: 
The response rate of study was 96.2%, 481 participants of 500 were included in study while other 
19 participants were excluded since they refused to participate.  
 More than half of them were females (56.1%). The mean age of the participants was 60 years. 
Two-3rds of the participants lived in rural areas. One quarter of the participants were illiterate 
(27.7%), around half of participants (43%) finished their primary education. Almost half of the 
participants (48.2%) had a monthly income less than 1500 shekels. The majority of the participants 
(79%) were unemployed and (79%) of the participants are married (79.8 %) as shown in table 
(5.1).  
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Table (5.1): Socio-demographic distribution of participants. 
Variable Frequency Percentage 
Sex  
        Male 211 43.9% 
        Female 270 56.1% 
Age  
        ≤50 87 .118 % 
        51-60 170 35.3% 
        61-70 145 30.1% 
<70 79 16.4% 
Residency  
        Urban 152 31.6% 
         Rural 329 68.4% 
Education level  
        Illiterate 133 27.7% 
        Primary school 208 43.2% 
        Secondary school 82 17% 
        University 58 12.1% 
Income Level  
<1500 232 48.2% 
          1500-3000 197 41% 
>3000 52 10.8% 
Employment  
          Yes 97 20.2% 
           No 384 79.8% 
Marital Status  
          Single 25 5.2% 
          Married 384 79.8% 
          Widowed 54 11.2% 
          Divorced 18 3.7% 
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5.2.2 Diabetes-related characteristics: 
 
- Disease Duration:  the mean duration of diabetes among participants was 9.4 years. One 
3rd of participants have diabetes for five years or less, while around a quarter of the 
participants (23.9%) had diabetes for 6-10 years as shown in figure (5.1).  
 
 
 
 
 
 
 
 
 
 
 
 
             Figure (5.1): Distribution of diabetes history among participants (%) 
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- Diabetes complications: nearly half of the participants (47.2%) have neuropathy, while 
one 3rd of them (36.4%) have hypertension, and (35%) have dyslipidemia. Figure (5.2) 
shows all diabetes complications among participants. 
 
Figure (5.2): Percentage of diabetes complications among participants. 
 
- Diabetes Treatment: the majority (76%) of patients are treated by oral tablets, while 
(10.6%) are treated by insulin only and (13%) are treated by insulin and oral tablets 
together. 
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5.2.3 Diabetes risk factors distribution: 
- Diet:  
The average mean of days in which patients eat fruits and vegetables were .6 5, 6.8 days 
respectively.  In addition, the means of consumed serving units of fruits and vegetables during 
these days were 1.4, 1.6 days respectively. The majority of patients didn’t add salt to the food and 
didn’t eat processed food. See tables (5.2, 5.3) for more details.  
Table (5.2): Dietary habits, fruits and vegetables consumption  
Habit Mean SD 
1- In a typical week, on how many days do you eat fruit?  6.49 days 0.692 
2- How many servings of fruit do you eat on one of those days? 1.37 
servings 
0.522 
3- In a typical week, on how many days do you eat vegetables? 6.79 days 0.450 
4- How many servings of vegetables do you eat on one of those 
days? 
1.63 
servings 
0.523 
 
Table (5.3): Dietary habits, salt and sauce consumption. 
Habit 
Frequency (%) 
Always Often Som
etim
es 
Rarel
y 
Never Don’t 
know 
5- How often do you add salt or a salty 
sauce such as soy sauce to your food 
right before you eat it or as you are 
eating it? 
2 (0.4) 5 (1) 13 
(2.7) 
117 
(24.3) 
344 
(71.5) 
0 (0) 
6- How often do you eat processed food 
high in salt? By processed food high 
in salt, I mean foods that have been 
altered from their natural state, such as 
packaged salty snacks, canned salty 
food 
0 (0) 4 
(0.8) 
28 
(5.8) 
61 
(12.7) 
388 
(80.7) 
0 (0) 
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- Physical activity:  
 
Most of patients don’t do moderate or vigorous-intensity activity (96.6%). The majority of the 
participants walk walking for at least 10 minutes a day (83.6%). The mean time of sitting 
(sedentary) per day was 3 hours. For more details check table (5.4). Analysis of physical activity 
according to Global Physical Activity Analysis guide shows that 83.1% of patients don’t meet the 
recommended MET value by WHO which shouldn’t be less than 600 minutes per week (WHO,  
Table (5.4): Participants physical activity (n = 481).  
No
. 
Physical Activity Frequency (%) 
Yes No 
1 Does your work involve vigorous-intensity activity that causes large 
increases in breathing or heart rate like [carrying or lifting heavy 
loads, digging or construction work] for at least 10 minutes 
continuously? 
95 
(19.8%) 
386 
(80.2%) 
2 Does your work involve moderate-intensity activity that causes 
small increases in breathing or heart rate such as brisk walking [or 
carrying light loads] for at least 10 minutes continuously? 
16 (3.4%) 461 
(96.6%) 
3 Do you walk or use a bicycle (pedal cycle) for at least 10 minutes 
continuously to get to and from places? 
402  
(83.6%) 
79 
(16.4%) 
4 Do you do any vigorous-intensity sports, fitness or recreational 
(leisure) activities that cause large increases in breathing or heart 
rate like [running or football] for at least 10 minutes continuously? 
0 (0%) 481 
(100%) 
5 Do you do any moderate-intensity sports, fitness or recreational 
(leisure) activities that cause a small increase in breathing or heart 
rate such as brisk walking, [cycling, swimming, volleyball] for at 
least 10 minutes? 
0 (0%) 481 
(100%) 
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- Smoking:  
 
Most of the patients were non-smokers 94.8%, while only 5% were smokers. 
 
5.3 Inferential analysis: 
 
5.3.1 Body mass index (BMI) changes: 
One- way ANOVA of repeated measures releaved that there is no significant difference between 
BMI levels in 1st, 2nd and 3rd visits (F= 2.74) (P>0.06).  
5.3.2 Cholesterol levels changes: 
 
Analysis by One- way ANOVA of repeated measures show there was a significant difference  
between cholesterol levels in 1st , 2nd and 3rd visits (F= 5.03) (P>0.00).levels of cholesterol  
have decreased from 1st visit to 3rd one. Check figure 5.3.  
 
                  Figure (5.3): Estimated Marginal Means of Cholesterol 
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5.3.3 Blood pressure: 
 
One- way ANOVA of repeated measures releaved that there is a significant difference in  
systolic and diastolic blood pressure levels between 1st, 2nd, and 3 rd visit (F =9.97 ) (P> 0.00),  
(F= 9.05)(P> 0.00) respectively.  
Results showed that patients with good systolic pressure (>130mmHg) percentage was decreased 
between the 1st to the last visit. While patients with good diastolic pressure (>80mmHg) was 
increased from 1st to 3rd visit (table 5.5).  
Table (5.5): Distribution of good and bad blood pressure in 1st and 3rd visit. 
 Frequency (%) 
Good systolic 1st visit 152 (31.6) 
Good systolic 3rd visit  119 (25.4) 
Good diastolic 1st visit 168 (35) 
Good diastolic 3rd  visit 247 (52.63) 
 
5.3.4 Waist circumference:  
One- Way ANOVA of repeated measures shows statistically significant difference in waist 
circumference levels between 1st, 2nd and 3rd vists (F= 4.43) (P0.012>). Waist cirumfernce levels 
have been decreased from 1st  visit to 3rd one. Check figure 5.4.  
35 
 
 
              Figure (5.4): Estimated Marginal Means of waist circumference. 
 
 
5.3.5 Changes in HbA1c levels among visits and distribution of controlled patients. 
 
Results of analysis by One- Way ANOVA of repeated measures show that levels of HbA1c is 
statistically differes between 1st, 2nd and 3rd visits (F= 7.44) (P>0.001). Levels of HbA1c have 
been decreased from 1st  vist to 3rd one , figure 5.5.  
Results also show increase in percent of patients who achieve good glycemic control 
(HbA1>7%), from 1st visit (32.8%) to (38.7%) in 3rd visit (Graph 5.6). 
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              Figure (5.5): Estimated Marginal Means of HbA1c 
 
 
 
Figure (5.6): Distribution of controlled and uncontrolled patients in 1st and 3rd visits. 
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5.3.6 Association between HbA1c and independent variables:  
 
Chi-square test was applied to check associations between independent variables and dependent 
variables. Patients were classified according to changes in HbA1c between 1st and 3rd visit, “Good 
HbA1c” if HbA1C was decreased, and “Bad HbA1c” if HbA1c was increased. 
 Results showed that sex was significantly associated with HbA1c (P> 0.01), age indicated 
significant association with HbA1c (P<0.001), disease duration was significantly associated with 
HbA1c (P>0.04), in addition, income level showed significant association with HbA1c changes 
(P>0.03). On the other hand, other variables wasn’t significantly associated with HbA1c, including 
education level, marital status, place of residency, employment status, changes in BMI, physical 
activity, cholesterol and waist circumference (table 5.6) 
Table (5.6): Associations between independent variables and HbA1c change.  
Variable Good HbA1c Bad HbA1c Chi square 
(p-value) Frequency (%) Frequency (%) 
Sex        Male 89 (42.1) 122 (57.8) 0.013*  
              Female 145 (53.7) 125 (46.2) 
Age (in years)    
        ≤50 59 (67.8) 28 (32.1) 0.00* 
51-60 65 (38.2) 105(61.7) 
61-70 78 (53.7) 67 (46.2) 
<70 32 (40.5) 47 (59.4) 
Residency    
        Urban 76 (50.0) 76 (50.0) 0.69 
         Rural 158 (48.0) 171 (51.9) 
Education level    
        Illiterate 67 (50.3) 66 (49.6) 0.63 
        Primary school 95 (45.6) 113 (54.3) 
        Secondary school 44 (53.6) 38 (46.3) 
        University 28 (48.2) 30 (51.7) 
Income Level (in Shekels)    
<1500 103 (44.3) 129 (55.6) 0.03* 
          1500-3000 110 (55.8) 87 (44.1) 
>3000 21 (40.3) 31 (59.6) 
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Table 5.6 continues 
 Good HbA1c Bad HbA1c P value 
 Frequency (%) Frequency (%)  
Employment    
        Employed 49 (50.5) 48 (49.4) 0.73 
        Non-employed 185 (48.1) 199 (51.8) 
Marital Status    
          Single 13 (52.0) 12 (48.0) 0.23 
          Married 186 (48.4) 198 (51.5) 
          Widowed 30 (55.5) 24 (44.4) 
          Divorced 5 (27.7) 13 (72.2) 
Disease duration (in years)    
           ≤5 60 (40.0) 90 (60.0) 0.04* 
           6-10 86 (54.7) 71 (45.2) 
           11-15 37 (45.1) 45 (54.8) 
           16-20 39 (57.3) 29 (42.6) 
            ≥21 11 (55.0) 9 (45.0) 
Cholesterol levels    
Decrease  129 (52.0) 119 (47.9) 0.14 
Increase  105 (45.0) 128 (54.9) 
BMI     
Decrease  118 (50.4) 116 (49.5) 0.46 
Increase  116 131 (53.0) 
Waist circumference     
Decrease  183 (54.3) 154 (45.6) 0.88 
Increase  99 (54.6) 82 (45.3) 
Physical activity  
MET >600 
MET  ≥600  
 
167(83.5) 
 33 (16.5) 
 
167(82.7) 
35 (17.3) 
0.49 
* P values are significant at α = 0.05 level 
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5.3.7 Logistic regression model: 
From the logistic regression model (Table 5.7), females showed higher significant association to 
improvement in HbA1c levels with an adjusted odds ratio 1.6. Patients with age group less than 
50 years indicated higher significant association to improvement in HbA1c level compared to age 
group more than 70 years (OR= 1.7, P<0.001). Income level “1500-3000” showed higher 
significant association to improvement in HbA1c level compared to “more than 3000” group (OR= 
2.4, P= 0.01). Patients who have diabetes forless than5 years have higher significant association 
to change HbA1c compared to more than 20 years (OR= 1.9, P<0.001). 
Table (5.7): Logistic model of variables associated to improvement in HbA1c. 
Variable AOR 95% CI P-value 
Age (years)    
Less than 40 2.7 1.53-5.25 .002 
41-50 .856 0.50-1.50 .583 
51-60 1.7 0.95-2.90 .067 
More than 60years* 1   
Sex    
Female 1.6 1.07- 2.35 0.01 
Male* 1   
Income Level (in Shekels)    
Less than 1500 1.6 0.84-3.2 .020 
1500-3000 2.4 1.36-5.48 .167 
More than 3000* 1   
Disease Duration    
Less than 5 years 1.9 0.12-0.93 .007 
6-10 years 1.5 0.26-1.93 .156 
11-15 years 2.4 0.19- 1.25 .005 
16-20 years 2.4 0.28- 2.33 .089 
More than 20 years* 1   
AOR: Adjusted Odds Ratio, 95%CI: 95% confidence interval, The Model includes: Age, gender, income level, 
disease duration, marital status, employment status, education level, place of residency, changes in BMI, cholesterol, 
waist circumference.  
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Chapter Six 
Discussion, Conclusion and Recommendations 
 
6.1 Discussion: 
The overall goal of PEN Approach was to provide effective and affordable prevention and 
treatment interventions to patients in low income countries (WHO, 2010). As previously outlined, 
program evaluation is an important tool to measure effectiveness of public health programs and 
assure it meets stated objectives.  
The study aimed to assess the impact of PEN Approach on the health status of diabetic patients by 
assessing diabetes controls mainly HbA1c which is recommended by ADA, as an indicator of 
glycemic control. Physical measurements including BMI, waist circumference, cholesterol and 
blood pressure were also checked at baseline and after two years of following the programme.  
The analysis of HbA1c showed significant decrease in HbA1c levels after two years of attending 
the PEN Approach compared to first time of approach involvement in the first visit (P>0.001). 
Furthermore, the percentage of patients who reported good glycemic control (HbA1c<7%) 
increased from 32.8% in the 1st visit to 38.7% in the 3rd one after two years. Our results are 
;consistent with study performed in USA (2017) to examine changes in HbA1c associated 
treatment intensification showed that patients who received early treatment intensification 
achieved significant reduction in HbA1c after one year of treatment (Fu, 2017). Another study was 
conducted in Brazil (2016) reported significant decline in HbA1c levels after six months of 
introducing mobile diabetes mellitus consultancy program (Filho, 2016). In Palestine, master 
thesis study, aimed to evaluate diabetes management program in Augusta Victoria hospital in 
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Jerusalem showed that 60% of patients developed good change in HbA1c levels after two years 
(Khatib, 2013).  
However, HbA1c has been used by clinicians as the major standard to measure patients’ glycemic 
control over the period of 2-3 months (ADA, 2007). This would facilitate clinicians’ treatment 
decisions in favor of glycemic control with the aim of reducing or avoiding complications 
associated with DMT2 (Sherwani, 2016). Concerning this point, the UK prospective diabetes study 
(UKPDS) predicted that reduction in the HbA1c level by 1%, will reduce the risk of micro-vascular 
complications by 37% (Stratton, 2000). 
Our findings indicated an increase in the percentage of patients with uncontrolled blood pressure, 
from 1st to 3rd visit after years. These results are inconsistent with other study conducted in 
Shanghai (2008) to evaluate community based-diabetes management program that showed 
significant decrease in patients’ blood pressure in intervention group compared to control group 
(Xiaolin, 2008). Also in Bhutan, a study was conducted to evaluate PEN Approach showed 
decrease in the percent of patients with uncontrolled blood pressure from at baseline 42% to 21.5% 
after three months (Wangchuk, 2014). 
Low-income level patients are usually dependent on governmental health insurance in Palestine 
(WHO, 2006). Shortage in medicine supply in governmental PHC facilities and the relative high 
cost of medication in the private sector would promote habitual trends among patients to disregard 
medication schedule. Missing doses, various medications with different intake schedule and 
ignorance of the importance of antihypertensive medications are, also, reasons for patient poor 
medication adherence (Devkota, 2016).  
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Clinic blood pressure measurements showed large variations which may results in inaccurate 
classification of patients (Engl, 2003). Reliable blood pressure measurements need rest period 
before measuring, adjustment of the cuff, and slow deflation of the cuff. Also blood pressure may 
be affected by clinical environment (Ghuman, 2009).  
The BMI is an index of body weight to height, and pointed out as an important risk factor of DMT2 
(Hu FB, 2001). Our results showed insignificant decrease in patients’ BMI between 1st and 3rd 
visit after two years (P<0.06). On the other hand, 64% of patients are still overweight (BMI>25) 
and 28% are still obese (BMI>30). A study in Jordan (2014) among Palestinian refugees showed 
a decrease in percent of patients with BMI >30 from 52% at baseline to 49% after two and half 
year (Khader, 2014). In Korea (2017), a study was conducted to evaluate piloting of PEN Approach 
showed decrease in percent of patients with BMI≥ 23 from 24.5% to 22.7% after one year of follow 
up (Hyon, 2017). Studies predicted that 5% reduction in the body weight results in significant 
improvement in HbA1c values after one year (Wing, 1987).  
Cholesterol levels showed significant decrease among patients between 1st and 3rd visit after two 
years (P <0.001). These results are consistent with a study in Korea (2017), in which patients with 
high levels of cholesterol (<200mg/dl) had decreased after one year of PEN Approach 
implementation (Hyon, 2017). While in Jordan (2014), a study showed that patients with good 
cholesterol levels (<200mg/dl) have decreased from 74% to 63% after two and half years (Khader, 
2014). 
Around 35% of our study participants have dyslipidemia and this condition is registered in 
patients’ files. This means that patients already take drugs to manage dyslipidemia and 
consequently the cholesterol level are expected to decrease. Also, measuring total cholesterol 
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doesn’t reflect the whole picture of lipids, low density cholesterol (LDL) and high density 
cholesterol (HDL) and triglycerides should be measured and considered. The American Heart 
Association (AHA) states that diabetes often lowers HDL “good” cholesterol levels and raises 
triglycerides and LDL “bad” cholesterol levels which will increase the risk for heart disease and 
stroke (AHA, 2016).  
The main goal of DMT2 management is to ensure optimal glycemic control. We have assessed the 
magnitude of good change in glycemic control and associated predictors among DMT2 patients. 
Binary Logistic model was applied to analyze association between predictors and changes in 
HbA1c levels, it showed that females achieved better improvement in HbA1c levels than males 
(OR=1.6, P<0.01). This result is consistent with other cross sectional study conducted in Oman 
(2012), showed that women reported better glycemic control than men (OR =1.5, P<0.001) (Al-
Lawati, 2012). Another study was conducted in Taiwan (2016) showed that although less number 
of women achieved controlled glycemic control (HbA1c<7%), but women registered significantly 
decline in HbA1c levels than men after ten years of follow up (BeLue, 2016). While, most previous 
studies showed better improvement in HbA1c levels in males rather than females (Balkau, 2015; 
Kautzky-Willer, 2015; Yousefzadeh, 2015). Most of our study participants were women and 
unemployed (housewives), this would reflects higher commitment to regular visits to PHCs among 
female patients. Participants’ selection was purposive, patients who visited clinic during the study 
period were selected. Men are usually employed might have lower commitment to follow-up 
scheduled visits.  
Age indicated that younger patients achieve better improvement in HbA1c levels rather than 
elderly (OR=2.7, P<0.001). This result is consistent with other study (2014), showed that HbA1c 
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levels increased by 0.085% per 10 years of age (Dubowitz, 2014). On the other hand, previous 
researches suggested that younger age associated with poor glycemic control (Schetman, 2002; 
Al-Lawati, 2012; Kamuhabwa, 2014). Elder patients wereless likely to exercise compared to 
young. This may be partially explained because younger patients may have better general health, 
and less co-morbidity compared to elderly. However, some studies suggested that HbA1c levels 
increases with age may be due to nonglycemic factors like alterations in red cell turnover or 
hemoglobin (Pani, 2008; Dubowitz, 2014).  
Diabetes duration showed association to improvement in glycemic control, patients who have 
DMT2 for less than 5 years showed better improvement in glycemic control  (OR=1.9, P<0.001). 
A study was conducted in California (2005) revealed that the longer duration with diabetes, the 
harder to maintain glycemic control. Although self-care skills might improve with longer duration 
diabetes, resistance to medication and the need for higher doses or additional medications increase 
over time (Benoit, 2005). 
Another study in Hong Kong (2012) found that patients with longer duration of diabetes and more 
complex treatment regimens were associated with poorer glycemic control (Ali MK, 2012). Juarez 
et al. (2012) also reported that patients who had had diabetes for 10 years were about nine times 
more likely to have poor glycemic control than those who had had diabetes for 3 years (Juarez, 
2012).  
DMT2 is a progressive disease and as glucose levels rise, more drugs are required to achieve 
control (Badedi, 2016). Insulin resistance increases with time due to progressive impairment of 
insulin secretion from beta cells (UKPDS, 1998).  
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Our findings indicated that income level associated with improvement in glycemic control, patients  
with middle category of income level (1500-3000 shekels) showed good improvement in glycemic 
control rather than others with higher income level <3000 Shekels (OR= 1.6, P=0.01).  A study 
was conducted in China (2016) showed that higher income patients in China tended to have worse 
HbA1c levels, and only 7.2 % of patients with the highest income achieved good glycemic control.  
A proportion lower than other two groups including middle and low income level (Tao X, 2016). 
The possible reasons for bad glycemic in the high income population involved a more expanded 
diet choices and ability to have any instrument may facilitate their lives and make it easier such as 
having a car so no need to walk for work.  
While a study in Canada (2016) revealed that poverty was related to poor glycemic control among 
patients with type 2 diabetes and explained this due to the way of patients perceive to their disease 
and copying with disease stress also to social inequality in health (Houle,2016).  
This study is the first one assessed health impact of PEN Approach in West Bank, by checking 
some predictors of glycemic control and examining changes in HbA1c levels as an indicator for 
glycemic control after two years of attending the Approach. However, international studies study 
impact of PEN Approach by using primary healthcare clinics as a unit of follow up, to check 
changes in physical and laboratory measurements, means at different points of time, percent of 
people who attending the clinic reached optimal recommended value. They didn’t check these 
changes in selected patients and follow them. This may fail in reflect actual impact of Approach  
on patients themselves since by the time new patients may attend approach and their readings out 
of recommended values. (Wangchuk, 2014; Hyon.2017).  
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The main limitation of the study that it is a cross sectional study, where it is inadequate to assess 
cause and effect relationships. The study didn’t consider other predictors of glycemic control such 
as adherence to drugs. In behavioral risk factors including diet, physical inactivity and smoking 
only core part of STEPwise is studied to check patients’ situation. This is because the study scope 
isn’t the behavioral risk factors. Also, since it was a file based study, human errorscould be 
occurred in registering measurements. HbA1c is a blood test, its results may differ due to technique 
used for measurement, no data about techniques used in selected clinics.  
Despite the previously stated limitations, the study yielded a number of important findings with 
implications that should be taken into consideration by the clinical researchers and healthcare 
policy makers for improving future practice.    
6.2 Conclusion: 
Overall, the results of this evaluation indicated that PEN Approach was effective in meeting some 
objectives, HbA1c levels among diabetic patients attending PHC implementing the PEN approach 
have significantly decline in HbA1c levels after two years, and percent of patients with controlled 
glycemic control increased after two years.  
On the other hand, despite patients showed significant decrease in cholesterol, and waist 
circumference, high percent of them still away from optimal recommended values. This could 
suggest some modifications in PEN Approach to meet the need for achieving better improvements, 
especially with high burden of diabetes complications among participants.   
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6.3 Recommendations: 
 
- For MoH:  
 Introduce screening for diabetes mellitus in primary healthcare clinics for adults 
especially adults with high risk.  
 To continue its strategy in diabetes management and introduce a comprehensive health 
education program through patient counseling, skills building and behavioral 
interventions to raise awareness among DMT2 patients about diabetes, its’ 
complications and the importance of good glycemic control.  
 Improve PEN protocols to achieve better glycemic control by make HbA1c every three 
months instead of six months especially for patients with uncontrolled HbA1c, and 
prevent diabetes mellitus complications by screening tests and early diagnosis.  
 Develop ongoing evaluation program to follow up health status of patients and assure that 
the Approach is applied properly, also conduct follow up visits to PHCs and check 
patients’ files.  
 Implement health information system, this will help healthcare workers to save time and 
create integration between clinics and hospitals systems for better management of 
diabetic patients.  It is also important to ensure completeness of patient files. 
- For future research:  
 Longitudinal studies in depth to study the cause-effect relationship between HbA1c and 
its predictors. This could be useful for decision makers to plan properly for diabetes 
management.  
 Study other predictors to glycemic control such as effect of patients’ adherence to 
drugs.  
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 Evaluate cost-effectiveness of the Approach as a protocol of diabetes management for 
low income-countries.   
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  برنامج الدراسات العليا  –كلية الصحة العامة 
 
 عنوان البحث : 
 setebaiD htiw stneitaP gnoma lortnoC cimecylG fo noitaulavE"
 "knaB tseW ni hcaorppA NEP eht gniwollof
م االموقع:حيث سيتم اجراء الدراسة في عيادات الرعاية الاولية التابعة لوزارة الصحة في شمال الخليل ور
 الله وجنين.
 gnoma lortnoC cimecylG fo noitaulavE“أنا الباحثة ايمان برادعية, أقوم ببحث بعنوان 
 ”knaB tseW ni hcaorppA NEP eht gniwollof setebaiD htiw stneitaP
 hcaorppA NEPوهو بحث يهتم بدراسة الوضع الصحي لمرضى السكري المسجلين على برنامج ال 
اسة سأقوم بتجميع معلومات من ملفاتكم لها علاقة بنتائج الفحوصات الطبية وقراءات خلال هذه الدر 
الضغط والسكر وكذلك تعبئة استبانة من خلال توجيه الاسئلة لكم.لن تستخدم هذه ا لمعلومات الا لاغراض 
 البحث العملي فقط .
هذا البحث خلال اي مرحلة  كمشارك فى هذا البحث العلمى لك الحرية في طرح أى سؤال أو إستفسار عن
من المرحل. يرجى العلم بأن المشاركة بهذا البحث عمل طوعي بحت ولكم الحرية المطلقة بالموافقة او 
 عدمها. قراركم بعدم المشاركة فى هذا البحث العلمى لا يترتب عليه اى تبعات.
ي. وأنا أعلم أنه يمكنني ان لقد قرأت الوصف أعلاه من هذه الدراسة. وقد تمت الاجابة على جميع أسئلت
 . أعطي موافقتي بحرية على المشاركة في هذه الدراسةارفض المشاركة. 
 توقيع المشارك: ...............................
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Demographic Information:                        
File #: .............................. 
Date of Birth:  .......................  
Sex:     
 Male  
 female 
Level of education:   
 Illiterate  
 Primary school. 
 Secondary school. 
 University.  
Level of income:  
 Less than 1500. 
 1500 – 3000 
 More than 3000.  
Place of residency:     
 Urban. 
 Rural. 
 Camps.  
Marital status:  
 Single. 
 Married. 
 Divorced. 
 Widowed. 
 
Employment: 
 Employed  
 Unemployed 
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Parameter  First visit After 1 year  After 2 year Note  
Date of diagnosis     
Height     
Weight     
Waist 
circumferences 
    
Blood pressure 
systolic/diastolic 
    
HbA1c     
Cholesterol     
Drug name     
Complications Retinopathy                       hypoglycemia 
Diabetic foot                      Nephropathy 
Neuropathy                       hypertension 
Dyslipidemia  
cutting any organ because of diabetes 
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 النشاط البدني :
  .نعم1
  .لا 2
  . 4اذا لا اذهب الى السؤال 
دقائق  01لمدة  هل طبيعة عملك تتطلب بذل نشاطا بدنيا شاقا-1
مستمرة عالأقل ويسبب زيادة كبيرة في التنفس وتسارع ضربات 
 القلب مثل (حمل أشياء ثقيلة, الحفر , أعمال المباني) ؟ 
  كم يوم في الاسبوع تقوم بنشاط شاق كجزء من عملك؟ -2 عدد الايام 
  م بنشاط شاق أثناء العمل ؟ كم من الوقت في اليوم الواحد تقو-3 دقيقة (......)      ساعة(.......) 
  .نعم 1
  .لا  2
  .7اذا كانت الاجابة لا اذهب الى سؤال 
هل طبيعة عملك تتطلب أنشطة متوسطة الجهد التي تسبب -4
زيادة بسيطة في التنفس و نبضات القلب مثل( المشي 
السريع, حمل أشياء خفيفة الوزن ) لمدة عشر دقائق 
 مسستمرة عالأقل. 
كم يوم من أيام الاسبوع تقوم بنشاط بدني متوسط كجزء من -5  ....) عدد الأيام (..
 عملك؟ 
كم من الوقت في اليوم الواحد تقوم بنشاط بدني متوسط كجزء -6 دقيقة(.........)       ساعة(........) 
 من عملك ؟ 
  .نعم 1
  .لا 2
  01اذا كانت الاجابة لا اذهب الى سؤال 
لى أماكن معينة لمدة عشر دقائق هل تسير على الأقدام من وا-7
 مستمرة على الأقل؟ 
كم يوما في الاسبوع تسير على الأقدام لمدة عشر دقائق مستمرة -8 عدد الأيام(......)
 عالأقل من والى أماكن معينه؟
  كم من الوقت تسير على الأقدام للتنقل في اليوم الواحد؟-9 دقيقه (.......)       ساعة(.......) 
  .نعم1
  .لا 2
  . 31اذا كانت الاجابة لا اذهب الى سؤال 
هل تقضي وقت الفراغ بنشاط شاق سواء كان للرياضه أو -01
اللياقه البدنيه أو النشاط الترفيهي تزيد مدته عن عن عشرة دقائق 
 مستمرة مثل( الجري أو كرة القدم) ؟ 
بدني شاق كجزء من كم يوما في الاسبوع الواحد تقوم بنشاط -11 عدد الايام(.....) 
 وقت فراغك كالجري أو رفع الأثقال أو القيام بأي رياضه شديده؟ 
كم من الوقت في اليوم تقوم بنشاط بدني شاق أثناء وقت -21 دقيقه(.......)     ساعة(......)
 الفراغ؟
  .نعم 1
  .لا 2
هل يشمل وقت فراغك القيام بأنشطة بدنية متوسطة -31
عالأقل في المرة الواحدة مثل( الجهد, لمدة عشر دقائق 
المشي السريع, السباحه, كرة اليد, ركوب الدراجة أو حمل 
 أشياء خفيفة الوزن) ؟ 
 
كم يوما في الاسبوع تقوم بأنشطة بدنية متوسطة أثناء وقت -41 عدد الأيام (......) 
 الفراغ؟ 
احد تقوم بنشاط بدني متوسط أثناء كم من الوقت في اليوم الو-51 دقيقه(......)       ساعه(.......) 
 وقت الفراغ؟ 
 
 
 
 
 
 
 66
 
 التغذية: 
 عدد الايام (......) 
  .3لا أعلم      اذا صفر اذهب الى   
  كم يوم في الاسبوع  تتناول الفواكه؟ -1
 عدد الحصص (....) 
 لا أعلم
  كم حصة فواكه تتناول في اليوم الواحد ؟ -2
 عدد الأيام (.....) 
 لا أعلم 
  كم يوم في الاسبوع تتناول الخضراوات؟-3
 عدد الحصص (......) 
 لا أعلم 
  كم حصة خضراوات تتناول في اليوم الواحد؟-4
 دائما -
 في كثير من الأحيان -
 بعض الأحيان -
 نادرا -
 أبدا -
 لا اعرف -
 
كم مرة تضيف الملح أو الصلصة المالحة مثل  -5
صلصة الصويا إلى طعامك قبل تناوله مباشرة أو 
 ؟تناوله أثناء
 
 دائما -
 في كثير من الأحيان -
 بعض الأحيان -
 نادرا -
 أبدا -
 لا اعرف -
المصنع عالي المحتوى كم مرة تتناول الطعام -6
؟ ، مثل الوجبات الخفيفة المالحة المعبأة ، بالملح
والأطعمة المالحة المعلبة بما في ذلك المخللات 
والمعلبات ، والأطعمة المالحة التي يتم إعدادها في 
 ؟للوجبات السريعة ، والجبن  مطعم
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 استخدام التبغ:
  .نعم1
  أ) 9.لا  ( اذا لا اذهب الى   ت2
هل سبق أن دخنت أي نوع من منتجات -1
التبغ مثل السجائر ,السيجار ,الغليون, الشيشة 
 أو المدواخ؟
  .نعم 1
  ) 6.لا ( اذا لا اذهب الى ت2
لغليون أو هل تدخن حاليا السجائر, السيجار, ا-2
 المدواخ؟ 
  .نعم 1
  أ) 6.لا ( اذهب الى ت2
اذا كان الجواب نعم, هل تدخن أي من هذه -3
 المنتجات يوميا؟  
 العمر بالسنوات (........) 
  أ 5لا أعلم, اذا كان معلوما اذهب الى ت
 
كم كان عمرك عندما بدأت بالتدخين -4
 يوميا؟ 
 سنوات مضت (.....) 
  أ.    5ان معلوما اذهب الى ت اذا ك              
اذا كنت لا تذكر كم كمرك عندما بدأت بالتدخين -5
فهل تذكر المده الزمنية التي استغرقتها منذ بدأت 
 بالتدخين؟ 
  (اختر اجابة واحده فقط)    
 
  لا أعلم 77       
 أو شهور مضت (.....)
  أ .5اذا كان معلوما اذهب الى ت              
  مضت (.....) أو أسابيع 
  ماهومعدل تدخينك لأي من هذه الأنواع ؟-6 سيجارة مصنعه (......) 
 (سجل كل واحده منها) 
  لا أعلم  77
 سيجارة لف (.......) 
 غليون (.......)
  سيجار -سيجار
 صغير  (........) 
 شيشة (.........) 
 مدواخ (.......) 
 أنواع اخرى (.......) 
  أ6انتقل الى تاو أنواع اخرى اخرى اذهب الى اذا انواع 
 اذكر ماهي الانواع (......) 
  .نعم 1
  .لا 2
في الاثني عشر شهر الماضية هل سبق أن حاولت -7
 الاقلاع عن التدخين ؟
  .نعم 1
  .لا 2
  .لا يوجد أي زيارة خلال الاثني عشر شهرا السابقة. 3
 خلال زيارتك لأي طبيب أو غيره من الكادر-8
الصحي في الاثني عشر شهر الماضية هل تم تقديم 
 نصيحه لك بالاقلاع عن تدخين التبغ؟
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  برنامج الدراسات العليا  –كلية الصحة العامة 
 
 عنوان البحث : 
 setebaiD htiw stneitaP gnoma lortnoC cimecylG fo noitaulavE"
 "knaB tseW ni hcaorppA NEP eht gniwollof
الموقع:حيث سيتم اجراء الدراسة في عيادات الرعاية الاولية التابعة لوزارة الصحة في شمال الخليل ورام 
 الله وجنين.
 gnoma lortnoC cimecylG fo noitaulavE“أنا الباحثة ايمان برادعية, أقوم ببحث بعنوان 
 ”knaB tseW ni hcaorppA NEP eht gniwollof setebaiD htiw stneitaP
 hcaorppA NEPوهو بحث يهتم بدراسة الوضع الصحي لمرضى السكري المسجلين على برنامج ال 
خلال هذه الدراسة سأقوم بتجميع معلومات من ملفاتكم لها علاقة بنتائج الفحوصات الطبية وقراءات  
اض معلومات الا لاغرالضغط والسكر وكذلك تعبئة استبانة من خلال توجيه الاسئلة لكم.لن تستخدم هذه ا ل
 البحث العملي فقط .
كمشارك فى هذا البحث العلمى لك الحرية في طرح أى سؤال أو إستفسار عن هذا البحث خلال اي مرحلة 
من المرحل. يرجى العلم بأن المشاركة بهذا البحث عمل طوعي بحت ولكم الحرية المطلقة بالموافقة او 
 لبحث العلمى لا يترتب عليه اى تبعات.عدمها. قراركم بعدم المشاركة فى هذا ا
لقد قرأت الوصف أعلاه من هذه الدراسة. وقد تمت الاجابة على جميع أسئلتي. وأنا أعلم أنه يمكنني ان 
توقيع                      .أعطي موافقتي بحرية على المشاركة في هذه الدراسةارفض المشاركة. 
 ...المشارك: ............................
 الباحث: ايمان برادعية 
 moc.liamg@aiyedarabname       7676108650الهاتف والبريد الالكتروني :       
 مشارك: د. معتصم حمدان (مشرف الرسالة) .أ
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Demographic Information:                        
File #: ..............................  
Date of Birth:  .......................  
Sex:     
 Male  
 female 
Level of education:   
 Illiterate  
 Primary school. 
 Secondary school. 
 University.  
Level of income:  
 Less than 1500. 
 1500 – 3000 
 More than 3000.  
Place of residency:     
 Urban. 
 Rural. 
 Camps.  
Marital status:  
 Single. 
 Married. 
 Divorced. 
 Widowed. 
 
Employment: 
 Employed  
 Unemployed 
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Parameter  First visit After 1 year  After 2 year Note  
Date of diagnosis     
Height     
Weight     
Waist 
circumferences 
    
Blood pressure 
systolic/diastolic 
    
HbA1c     
Cholesterol     
Urine albumin     
Drug name     
Complications Retinopathy                       hypoglycemia 
Diabetic foot                      Nephropathy 
Neuropathy                       hypertension 
Dyslipidemia  
cutting any organ because of diabetes 
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Physical Activity Part:  
1- Does your work involve vigorous-intensity activity 
that causes large increases in breathing or heart rate 
like [carrying or lifting heavy loads, digging or 
construction work] for at least 10 minutes 
continuously? 
 
-Yes                            - No 
 (If No, go to question 4). 
 
2- In a typical week, on how many days do you do 
vigorous intensity activities as part of your work?   
 
Number of days........... 
3- How much time do you spend doing vigorous-
intensity activities at work on a typical day? 
 
Hours   .........  minutes........... 
4- Does your work involve moderate-intensity activity 
that causes small increases in breathing or heart rate 
such as brisk walking [or carrying light loads] for at 
least 10 minutes continuously? 
 
-Yes                            - No 
 (If No, go to question 7). 
 
5- In a typical week, on how many days do you do 
moderateintensity activities as part of your work? 
Number of days........... 
6- How much time do you spend doing moderate-
intensity activities at work on a typical day? 
Hours   .........  minutes........... 
7- Do you walk or use a bicycle (pedal cycle) for at 
least 10 minutes continuously to get to and from 
places? 
-Yes                            - No 
 (If No, go to question 10). 
 
8- In a typical week, on how many days do you walk or 
bicycle for at least 10 minutes continuously to get to 
and from places? 
Number of days........... 
9- How much time do you spend walking or bicycling 
for travel on a typical day? 
Hours   .........  minutes........... 
10- Do you do any vigorous-intensity sports, fitness or 
recreational (leisure) activities that cause large 
increases in breathing or heart rate like [running or 
football] for at least 10 minutes continuously? 
-Yes                            - No 
 (If No, go to question 13). 
 
11- In a typical week, on how many days do you do 
vigorousintensity sports, fitness or recreational 
(leisure) activities? 
Number of days........... 
12- How much time do you spend doing vigorous-
intensity sports, fitness or recreational activities on a 
typical day? 
Hours   .........  minutes........... 
13- Do you do any moderate-intensity sports, fitness or 
recreational (leisure) activities that cause a small 
increase in breathing or heart rate such as brisk 
walking, [cycling, swimming, and volleyball] for at 
least 10 minutes continuously? 
-Yes                            - No 
 (If No, go to question 16). 
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14- In a typical week, on how many days do you do 
moderateintensity sports, fitness or recreational 
(leisure) activities? 
Number of days........... 
15- How much time do you spend doing moderate-
intensity sports, fitness or recreational (leisure) 
activities on a typical day? 
Hours   .........  minutes........... 
16- How much time do you usually spend sitting or 
reclining on a typical day? 
Hours   .........  minutes........... 
 
 
 
Diet:  
7- In a typical week, on how many days do you eat 
fruit?  
Number of days....... 
 Don't Know 
)If zero, go to question 3) 
8- How many servings of fruit do you eat on one of 
those days? 
Number of servings....... 
 Don't Know 
9- In a typical week, on how many days do you eat 
vegetables? 
Number of days....... 
 Don't Know 
)If zero, go to question 5) 
10- How many servings of vegetables do you eat on one 
of those days? 
Number of servings....... 
 Don't Know 
11- How often do you add salt or a salty sauce such as 
soy sauce to your food right before you eat it or as 
you are eating it? 
- Always  
-  Often  
-  Sometimes  
-  Rarely  
- Never  
-  Don't know 
12- How often do you eat processed food high in salt? 
By processed food high in salt, I mean foods that 
have been altered from their natural state, such as 
packaged salty snacks, canned salty food including 
pickles and preserves, salty food prepared at a fast 
food restaurant, cheese, bacon and processed meat 
- Always  
-  Often  
-  Sometimes  
-  Rarely  
- Never  
-  Don't know 
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Tobacco use  
1- Do you currently smoke any tobacco products, such 
as cigarettes, cigars or pipes? 
- Yes 
- No 
(If No , go to question 8) 
2- Do you currently smoke tobacco products daily? - Yes 
- No 
3- How old were you when you first started smoking? Age.......  (years) 
Don’t know 
4- Do you remember how long ago it was? - In Years (...) 
- Or in Months (…) 
- Or in Weeks (…) 
5- On average, how many of the following products do 
you smoke each day/week? 
Product                     weekly           
daily  
Manufactured cigarettes …….           
……… 
Hand-rolled cigarettes     …….           
…….. 
Pipes full of tobacco         …….           
…….. 
Cigars, cheroots, cigarillos ……          
…….. 
Number of Shisha sessions …..          
……. 
Other                                      ……        
…….. 
Specify other.............. 
 
